The widely invasive type is more likely to show recurrence and distant metastasis than the minimally invasive type, resulting in a poorer prognosis (see CQ22). In this CQ, how to manage the widely invasive type diagnosed on pathological examination is investigated.
Distant Metastasis Total Thyroidectomy Differentiate Thyroid Carcinoma Major Adverse Event Follicular Carcinoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428 (RS)PubMedCrossRefGoogle Scholar
Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463 (NR)PubMedCrossRefGoogle Scholar
Sawka AM, Brierley JD, Tsang RW et al (2008) An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 37:457–480 (SR < RS>)PubMedCrossRefGoogle Scholar
Sampson E, Brierley JD, Le LW et al (2007) Clinical management and outcome of papillary and follicular(differentiated)thyroid cancer presenting with distant metastasis at diagnosis. Cancer 110:1451–1456 (RS)PubMedCrossRefGoogle Scholar
McGriff NJ, Csako G, Gourgiotis L et al (2002) Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34:554–564 (RS)PubMedCrossRefGoogle Scholar